Impact of Body Mass Index on Complications and Survival after Surgery for Esophageal and Gastro-Esophageal-Junction Cancer. (December 2017)

• Record Type: Journal Article
• Authors: Kruhlikava, I.; Kirkegård, J.; Mortensen, F. V.; Kjær, D. W.
• Is Part Of: Scandinavian journal of surgery. Volume 106:Number 4(2017)
• Page Start: 305
• Page End: 310
• Publication Date: 2017-12
• Subjects: Esophageal cancer -- esophagectomy -- body mass index -- obesity -- prognosis -- esophageal surgery; Surgery -- Periodicals; 617.005
• DOI: 10.1177/1457496916683097
• Languages: English
• ISSNs: 1457-4969

Abstract

Background and Aims: The impact of body mass index on complications and survival in patients undergoing esophagectomy has been extensively studied with conflicting results. In this study, we assess the impact of body mass index on complications and survival following surgery for esophageal and gastro-esophageal-junction cancer in a Danish population. Material and Methods: We identified 285 consecutive patients, who underwent curative-intended treatment for esophageal and gastro-esophageal-junction cancer in the period 2003–2010. We manually reviewed the electronic medical records of all patients included in the study. Body mass index was calculated as weight in kilograms divided by height in meters squared. We grouped patients according to their body mass index, using the World Health Organization definition, as underweight (body mass index < 18.5 kg/m 2 ), normal weight (body mass index: 18.5–24.9 kg/m 2 ), overweight (body mass index: 25–29.9 kg/m 2 ), and obese (body mass index ⩽ 30 kg/m 2 ). Results: Median age at surgery was 65 years (range: 27–84 years), of which 207 (72.6%) were males. Patients with the lowest body mass index and the obese patients seemed to have a higher frequency of minor complications. Anastomotic leakage occurred in less than 10% of the patients and was equally distributed across the groups as was the other major complications. There were no differences in the 1-, 2-, or 5-year survival rates between the four body mass index groups after adjustment for possible confounders. Five-year survival rates for the four body mass index groups were 31.8%, 28.7%, 27.9%, and 26.1%, respectively. Conclusion: Body mass index over 30 or under 18.5 does not seem to affect survival rates or the presence of serious postoperative complications following esophagectomy in patients with esophageal and gastro-esophageal-junction cancers not receiving neoadjuvant oncological treatment.